|
|
 |
|
Viewing report
|
|
|
|
Company Financials: Discovery Laboratories, Inc.
Datamonitor, Jan 2010
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
- Provides key ratios
- Includes information on revenue distribution by business segments and geographies
Highlights of this title
Discovery Laboratories (Discovery Labs) is a biotechnology company engaged in the development and commercialization of surfactant replacement therapies (SRT) for respiratory disorders and diseases.
The company is currently focused on developing lead products Surfaxin (lucinactant), Surfaxin LS and Aerosurf (lucinactant for inhalation), to address the most significant respiratory conditions affecting pediatric populations.
Key reasons to purchase this title
- Access important financial information and analysis on the company in a single datapack
- Understand the financial evolution of the five company over the last years.
- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
Customers who bought this item also bought
Company Financials: Abbott Laboratories
Company Financials: Gilead Sciences, Inc.
Company Financials: Amgen, Inc.
Company Financials: GTx, Inc.
Company Financials: Incyte
Company Financials: Idenix Pharmaceuticals, Inc.
Company Financials: Adolor Corporation
Company Financials: Array Biopharma Inc.
Company Financials: Isis Pharmaceuticals, Inc.
Company Financials: Exelixis
|
|
|
|
